Last 7 days
-1.1%
Last 30 days
-4.1%
Last 90 days
-0.1%
Trailing 12 Months
-16.7%
Datesorted ascending | Fund Name | Type | % Chg | $ Change | $ Held | % Portfolio |
---|---|---|---|---|---|---|
2023-09-12 | Farther Finance Advisors, LLC | added | 42.25 | 4,281 | 38,291 | 0.01% |
2023-09-08 | TUCKER ASSET MANAGEMENT LLC | unchanged | - | -1,199 | 4,549 | -% |
2023-08-24 | Alberta Investment Management Corp | unchanged | - | -59,940 | 227,472 | -% |
2023-08-22 | VIRGINIA RETIREMENT SYSTEMS ET AL | sold off | -100 | -5,200,720 | - | -% |
2023-08-21 | BOKF, NA | reduced | -27.27 | -2,236 | 3,033 | -% |
2023-08-21 | VisionPoint Advisory Group, LLC | new | - | 379 | 379 | -% |
2023-08-21 | TEACHERS RETIREMENT SYSTEM OF THE STATE OF KENTUCKY | reduced | -0.49 | -3,116,000 | 11,550,000 | 0.11% |
2023-08-21 | OSAIC HOLDINGS, INC. | unchanged | - | -4,900 | 18,803 | -% |
2023-08-21 | OSAIC HOLDINGS, INC. | reduced | -0.2 | -1,597,040 | 6,187,280 | 0.01% |
2023-08-21 | CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | reduced | -3.47 | -4,045,210 | 13,095,600 | 0.02% |
Date Filed | Name of Filer | Percent of Class | No. of Shares | Form Type | |
---|---|---|---|---|---|
Feb 09, 2023 | vanguard group inc | 9.66% | 2,391,436 | SC 13G/A | |
Feb 09, 2023 | fmr llc | - | 0 | SC 13G/A | |
Feb 01, 2023 | blackrock inc. | 6.4% | 1,582,313 | SC 13G/A | |
Apr 11, 2022 | schwartz alice n | 89.7% | 4,555,452 | SC 13D/A | |
Feb 09, 2022 | fmr llc | - | 0 | SC 13G/A | |
Feb 09, 2022 | vanguard group inc | 9.21% | 2,287,465 | SC 13G/A | |
Feb 01, 2022 | blackrock inc. | 7.1% | 1,768,081 | SC 13G/A | |
Feb 10, 2021 | vanguard group inc | 9.18% | 2,272,373 | SC 13G/A | |
Feb 08, 2021 | fmr llc | - | 0 | SC 13G | |
Jan 29, 2021 | blackrock inc. | 7.6% | 1,892,336 | SC 13G/A |
Date Filed | Form Type | Document | |
---|---|---|---|
Sep 14, 2023 | 3 | Insider Trading | |
Sep 06, 2023 | 4 | Insider Trading | |
Sep 06, 2023 | 4 | Insider Trading | |
Sep 06, 2023 | 4 | Insider Trading | |
Sep 06, 2023 | 4 | Insider Trading | |
Sep 06, 2023 | 4 | Insider Trading | |
Sep 06, 2023 | 4 | Insider Trading | |
Sep 06, 2023 | 4 | Insider Trading | |
Sep 06, 2023 | 4 | Insider Trading | |
Sep 06, 2023 | 4 | Insider Trading |
Name | Mkt Capsorted ascending | Revenue | Price %, 1M | Returns, 1Y | P/E | P/S | Rev 1-Yr | Inc 1-Yr |
---|---|---|---|---|---|---|---|---|
LARGE-CAP | ||||||||
A | 33.0B | 7.0B | -5.38% | -12.23% | 29.09 | 4.71 | 5.03% | -14.68% |
MTD | 24.7B | 4.0B | -3.30% | -3.12% | 27.83 | 6.25 | 2.30% | 16.37% |
ILMN | 21.9B | 4.5B | -17.36% | -28.94% | -5.22 | 4.9 | -4.92% | -21931.58% |
WAT | 16.2B | 3.0B | 2.60% | -2.79% | 23.99 | 5.41 | 3.16% | -3.93% |
PKI | 16.1B | 2.8B | -15.95% | -22.45% | 19.74 | 5.69 | -24.31% | 21.35% |
MID-CAP | ||||||||
SMALL-CAP | ||||||||
PACB | 2.4B | 146.1M | -8.89% | 61.75% | -7.4 | 16.16 | 4.72% | -55.19% |
QTRX | 960.9M | 112.0M | 5.18% | 169.83% | -14.6 | 8.58 | 0.83% | 16.42% |
ADPT | 749.3M | 189.6M | -19.57% | -31.57% | -3.92 | 3.95 | 18.74% | 17.75% |
HBIO | 175.0M | 114.1M | -1.44% | 44.37% | -32.24 | 1.53 | -5.49% | -48.58% |
CDXS | 118.7M | 99.2M | -1.73% | -74.89% | -2.09 | 1.2 | -26.56% | -199.52% |
BNGO | 99.7M | 31.5M | -1.32% | 40.85% | -0.68 | 3.16 | 35.12% | -38.47% |
NSTG | 73.7M | 143.9M | -41.73% | -89.43% | -0.44 | 0.51 | 0.71% | -18.99% |
CSBR | 72.1M | 52.7M | -20.39% | -41.08% | -9.55 | 1.37 | 2.10% | -1984.29% |
PSNL | 64.0M | 67.1M | -25.42% | -59.63% | -0.58 | 0.95 | -12.13% | -17.68% |
12.2%
12.4%
4.1%
-10.8%
68.8%
43.9%
16.1%
Y-axis is the maximum loss one would have experienced if Bio Rad Laboratories was unfortunately bought at previous high price.
Income Statement (Last 12 Months) | (In Millions) | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Description | (%) Q/Q | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 | 2018Q4 | 2018Q3 | 2018Q2 |
Revenue | -0.4% | 2,769 | 2,779 | 2,802 | 2,805 | 2,871 | 2,896 | 2,923 | 2,980 | 2,880 | 2,701 | 2,546 | 2,380 | 2,294 | 2,329 | 2,312 | 2,304 | 2,289 | 2,292 | 2,289 | 2,294 | 2,283 |
Gross Profit | -2.1% | 1,495 | 1,527 | 1,567 | 1,570 | 1,634 | 1,640 | 1,638 | 1,698 | 1,629 | 1,521 | 1,438 | 1,308 | 1,248 | 1,263 | 1,257 | 1,259 | 1,239 | 1,233 | 1,223 | 1,236 | 1,248 |
S&GA Expenses | 0.0% | 855 | 855 | 828 | 837 | 842 | 848 | 877 | 873 | 855 | 831 | 799 | 795 | 799 | 811 | 825 | 824 | 824 | 833 | 835 | 823 | 820 |
R&D Expenses | 0.3% | 267 | 267 | 257 | 253 | 247 | 246 | 261 | 259 | 254 | 242 | 218 | 218 | 206 | 204 | 203 | 199 | 200 | 197 | 199 | 222 | 235 |
EBITDA | 100.0% | - | -202 | -4,666 | -7,803 | -2,594 | -224 | 5,440 | 8,561 | 5,228 | 5,464 | 5,071 | 4,693 | 2,673 | 2,197 | 2,426 | 685 | 1,371 | 942 | 678 | 1,755 | 1,444 |
EBITDA Margin | 100.0% | - | -0.07* | -1.67* | -2.78* | - | -0.08* | 1.86* | 2.87* | 1.82* | 2.02* | 1.99* | 1.97* | 1.17* | 0.94* | 1.05* | 0.30* | 0.60* | 0.41* | 0.30* | 0.77* | 0.63* |
Interest Expenses | 3.5% | 48.00 | 46.00 | 38.00 | 27.00 | 16.00 | 5.00 | 2.00 | 6.00 | 11.00 | 17.00 | 22.00 | 23.00 | 23.00 | 23.00 | 23.00 | 23.00 | 24.00 | 24.00 | 24.00 | 24.00 | 23.00 |
Earnings Before Taxes | -114.0% | -526 | -245 | -4,704 | -7,824 | -2,593 | -216 | 5,449 | 8,565 | 5,227 | 5,317 | 4,918 | 4,529 | 2,509 | 2,033 | 2,261 | 520 | 1,206 | 776 | 513 | 1,600 | 1,280 |
EBT Margin | 100.0% | - | -0.09* | -1.68* | -2.79* | - | -0.08* | 1.86* | 2.87* | 1.81* | 1.96* | 1.93* | 1.90* | 1.09* | 0.87* | 0.98* | 0.23* | 0.53* | 0.34* | 0.22* | 0.69* | 0.56* |
Net Income | -124.0% | -428 | -191 | -3,627 | -6,027 | -1,935 | -93.15 | 4,254 | 6,666 | 4,051 | 4,100 | 3,806 | 3,521 | 1,947 | 1,579 | 1,759 | 377 | 905 | 574 | 366 | 1,277 | 1,030 |
Net Income Margin | 100.0% | - | -0.07* | -1.29* | -2.15* | - | -0.03* | 1.45* | 2.23* | 1.40* | 1.52* | 1.50* | 1.48* | 0.85* | 0.68* | 0.76* | 0.16* | 0.40* | 0.25* | 0.16* | 0.56* | 0.45* |
Free Cashflow | -100.0% | - | 127 | 82.00 | 152 | 364 | 459 | 536 | 667 | 586 | 529 | 476 | 369 | 322 | 381 | 359 | 272 | 244 | 162 | 156 | 148 | 116 |
Balance Sheet | (In Millions) | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Description | (%) Q/Q | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 | 2018Q4 | 2018Q3 | 2018Q2 |
Assets | -12.4% | 11,978 | 13,667 | 13,502 | 12,058 | 12,682 | 14,374 | 17,799 | 19,953 | 15,118 | 13,933 | 12,973 | 12,021 | 10,097 | 8,684 | 8,009 | 7,177 | 7,647 | 6,863 | 5,611 | 6,719 | 6,386 |
Current Assets | -4.2% | 3,139 | 3,277 | 3,158 | 3,140 | 3,250 | 3,303 | 1,990 | 2,466 | 2,289 | 2,175 | 2,140 | 2,324 | 2,133 | 2,083 | 2,180 | 2,048 | 2,088 | 2,032 | 2,023 | 2,034 | 1,992 |
Cash Equivalents | -16.0% | 390 | 464 | 434 | 518 | 597 | 802 | 471 | 860 | 733 | 673 | 662 | 840 | 608 | 604 | 663 | 561 | 581 | 456 | 434 | 435 | 403 |
Inventory | 3.1% | 777 | 753 | 719 | 686 | 657 | 605 | 572 | 589 | 599 | 605 | 622 | 640 | 628 | 557 | 554 | 588 | 590 | 590 | 584 | 601 | 591 |
Net PPE | - | - | - | 499 | - | - | - | 512 | - | - | - | 491 | - | - | 486 | 499 | 496 | 499 | 503 | 509 | 484 | 490 |
Goodwill | 0.9% | 412 | 408 | 406 | 400 | 347 | 346 | 347 | 292 | 292 | 292 | 292 | 292 | 292 | 264 | 264 | 264 | 235 | 231 | 220 | 502 | 500 |
Liabilities | -9.5% | 3,531 | 3,904 | 3,886 | 3,605 | 3,760 | 4,191 | 4,114 | 4,621 | 3,523 | 3,324 | 3,093 | 3,196 | 2,744 | 2,391 | 2,254 | 2,046 | 2,160 | 1,999 | 1,591 | 1,818 | 1,747 |
Current Liabilities | -1.3% | 582 | 590 | 569 | 571 | 614 | 648 | 681 | 650 | 587 | 610 | 632 | 987 | 927 | 869 | 905 | 434 | 446 | 444 | 451 | 453 | 442 |
Long Term Debt | - | - | - | 1,198 | - | - | - | 11.00 | - | - | - | 12.00 | - | - | - | 14.00 | - | - | - | 439 | 439 | 439 |
LT Debt, Non Current | 0.0% | 1,198 | 1,198 | 1,198 | 1,197 | 1,197 | 1,197 | 11.00 | 11.00 | 11.00 | 11.00 | 12.00 | 12.00 | 12.00 | 12.00 | 14.00 | 438 | 438 | 438 | 439 | - | - |
Shareholder's Equity | -13.5% | 8,447 | 9,764 | 9,615 | 8,454 | 8,945 | 10,203 | 13,685 | 15,332 | 11,595 | 10,609 | 9,890 | 8,825 | 7,353 | 6,293 | 5,757 | 5,131 | 5,487 | 4,864 | 4,020 | 4,900 | 4,639 |
Retained Earnings | -11.7% | 8,805 | 9,967 | 9,898 | 9,047 | 9,210 | 10,138 | 13,525 | 15,081 | 11,159 | 10,245 | 9,268 | 8,429 | 7,123 | 6,157 | 5,471 | 4,917 | 5,185 | 4,586 | 3,722 | 4,551 | 4,281 |
Additional Paid-In Capital | 2.3% | 474 | 463 | 447 | 431 | 472 | 459 | 442 | 421 | 460 | 445 | 429 | 412 | 429 | 424 | 410 | 396 | 411 | 403 | 394 | 382 | 377 |
Accumulated Depreciation | - | - | - | 1,009 | - | - | - | 1,002 | - | - | - | 961 | - | - | 876 | 883 | 851 | 850 | 828 | 818 | 812 | 799 |
Shares Outstanding | -0.8% | 29.00 | 30.00 | - | 30.00 | 30.00 | 30.00 | - | 30.00 | 30.00 | 30.00 | - | 30.00 | 30.00 | 30.00 | - | 30.00 | 30.00 | 30.00 | - | 30.00 | 30.00 |
Cashflow (Last 12 Months) | (In Millions) | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Description | (%) Q/Q | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 | 2018Q4 | 2018Q3 | 2018Q2 |
Cashflow From Operations | 18.5% | 287 | 242 | 194 | 275 | 505 | 606 | 669 | 793 | 698 | 636 | 585 | 450 | 414 | 478 | 458 | 403 | 366 | 288 | 286 | 250 | 216 |
Share Based Compensation | - | - | - | - | - | - | - | - | - | - | - | - | 43.00 | 36.00 | - | - | 36.00 | 33.00 | - | - | - | - |
Cashflow From Investing | 47.7% | -189 | -361 | -1,207 | -1,705 | -1,709 | -1,665 | -797 | -289 | -117 | -105 | -69.89 | -71.34 | -272 | -198 | -208 | -202 | -122 | -190 | -186 | -145 | -130 |
Cashflow From Financing | -38.3% | -293 | -212 | 974 | 1,065 | 1,058 | 1,182 | -55.43 | -481 | -465 | -471 | -523 | -105 | -110 | -123 | -22.76 | -64.98 | -62.66 | -49.03 | -48.68 | 2.00 | 1.00 |
Buy Backs | - | 181 | - | 216 | 125 | 125 | - | 50.00 | 50.00 | 50.00 | 50.00 | 100 | 108 | 113 | 128 | 28.00 | 69.00 | 64.00 | 49.00 | 49.00 | - | 2.00 |
Condensed Consolidated Statements of Income (Unaudited) - USD ($) shares in Thousands, $ in Thousands | 3 Months Ended | 6 Months Ended | ||
---|---|---|---|---|
Jun. 30, 2023 | Jun. 30, 2022 | Jun. 30, 2023 | Jun. 30, 2022 | |
Net sales | $ 681,110 | $ 691,099 | $ 1,357,954 | $ 1,391,161 |
Cost of goods sold | 318,627 | 296,068 | 633,054 | 593,495 |
Gross profit | 362,483 | 395,031 | 724,900 | 797,666 |
Selling, general and administrative expense | 207,824 | 207,793 | 433,377 | 404,485 |
Research and Development Expense | 65,042 | 64,346 | 139,993 | 123,881 |
Segment profit (loss) | 89,617 | 122,892 | 151,530 | 269,300 |
Interest expense | 12,343 | 10,720 | 24,680 | 14,768 |
Foreign exchange (gains) losses, net | (1,253) | 897 | (3,600) | (1,231) |
Marketable Securities, Unrealized (Gain) Loss | 1,595,442 | 1,338,190 | 1,612,967 | 5,883,307 |
Other Nonoperating Income (Expense) | 16,488 | 6,710 | 66,919 | 39,307 |
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest | (1,500,427) | (1,220,205) | (1,415,598) | (5,588,237) |
(Provision) benefit for income taxes | 338,176 | 295,091 | 322,309 | 1,295,776 |
Net income attributable to Bio-Rad | $ (1,162,251) | $ (925,114) | $ (1,093,289) | $ (4,292,461) |
Basic earnings per share: | ||||
Net income per share basic attributable to Bio-Rad | $ (39.59) | $ (31.05) | $ (37.09) | $ (143.74) |
Weighted average common shares - basic | 29,355 | 29,794 | 29,475 | 29,863 |
Diluted earnings per share: | ||||
Weighted average common shares - diluted | 29,355 | 29,794 | 29,475 | 29,863 |
Condensed Consolidated Balance Sheets (Unaudited) - USD ($) $ in Thousands | Jun. 30, 2023 | Dec. 31, 2022 |
---|---|---|
ASSETS: | ||
Cash and cash equivalents | $ 390,001 | $ 434,215 |
Short-term investments | 1,332,685 | 1,356,457 |
Restricted investments | 5,560 | 5,560 |
Accounts receivable, net | 491,575 | 494,645 |
Inventory | 776,600 | 719,316 |
Prepaid expenses | 122,641 | 124,179 |
Other current assets | 19,804 | 23,604 |
Total current assets | 3,138,866 | 3,157,976 |
Property, plant, and equipment | 1,575,075 | 1,508,020 |
Less: accumulated depreciation and amortization | 1,061,062 | 1,009,408 |
Property, plant and equipment, net | 514,013 | 498,612 |
Operating lease right-of-use assets | 173,922 | 180,952 |
Goodwill, net | 411,519 | 406,488 |
Purchased intangibles, net | 328,710 | 332,147 |
Other investments | 7,311,135 | 8,830,892 |
Other assets | 100,064 | 94,599 |
Assets | 11,978,229 | 13,501,666 |
LIABILITIES AND STOCKHOLDERS' EQUITY: | ||
Accounts payable | 149,535 | 135,041 |
Accrued payroll and employee benefits | 154,704 | 194,790 |
Current maturities of long-term debt and notes payable | 476 | 465 |
Income and other taxes payable | 74,481 | 32,428 |
Current operating lease liabilities | 36,543 | 36,336 |
Other current liabilities | 166,243 | 169,648 |
Total current liabilities | 581,982 | 568,708 |
Long-term debt, net of current maturities | 1,198,384 | 1,197,716 |
Deferred income taxes | 1,401,827 | 1,770,481 |
Operating lease liabilities | 146,849 | 153,597 |
Other long-term liabilities | 202,294 | 195,912 |
Total liabilities | 3,531,336 | 3,886,414 |
Stockholders' equity: | ||
Additional paid-in capital | 473,872 | 447,454 |
Retained earnings | 8,804,664 | 9,898,203 |
Accumulated other comprehensive loss | (372,862) | (466,822) |
Total stockholders' equity | 8,446,893 | 9,615,252 |
Total liabilities and stockholders' equity | 11,978,229 | 13,501,666 |
Common Class A [Member] | ||
Stockholders' equity: | ||
Common stock | 2 | 2 |
Common Class B [Member] | ||
Stockholders' equity: | ||
Common stock | 1 | 1 |
Treasury Class A [Member] | ||
Stockholders' equity: | ||
Treasury stock | $ (458,784) | $ (263,586) |
Treasury Stock, Common | ||
Stockholders' equity: | ||
Treasury Stock, Shares | 1,160,074 | 640,492 |